| Financial Year |
March 31 2023 |
| Monetary Funds |
465,092,522.18 |
| Held-for-trading Financial Assets |
671,647,681.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
148,259,308.49 |
| Advances to Suppliers |
16,837,415.34 |
| Other Receivables |
5,268,200.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
81,073,585.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,440,750.28 |
| Total Current Assets |
1,403,269,464.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,330.56 |
| Fixed Assetes |
150,642,502.95 |
| Under-construction Projects |
46,485,037.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,496,544.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,289,351.64 |
| Deferred Income Tax Assets |
2,276,732.83 |
| Other Non-Current Assets |
19,146,300.35 |
| Sub-Total of Non-Current Assets |
296,436,230.65 |
| Total Assets |
1,699,705,694.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
74,667,415.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,284,050.41 |
| Taxes Payable |
10,266,334.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,495,361.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,385,104.36 |
| Other Current Liabilities |
9,776,278.76 |
| Sub-Total of Current Liabilities |
140,041,728.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,448,702.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,853,320.31 |
| Total Liabilities |
149,895,049.22 |
| Paid-In Capital(Or Share Stock) |
134,341,400.00 |
| Capital Surplus |
1,036,833,996.22 |
| Surplus Reserve |
28,792,265.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
304,417,353.50 |
| Minority Stockholder's Interest |
45,429,509.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,504,381,135.80 |
| Owner's Equity（Stockholder's Equity） |
1,549,810,645.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,699,705,694.73 |
